| abstract |
FIELD: medicine, medicinal preparations, pharmacy. n SUBSTANCE: invention proposes a new complex comprising at least one substance taken among the group: osteoclastogenesis-inhibitory factor (OCIF), its analogues and its variants that are bound with a substance taken among the group consisting of polysaccharides and their derivatives. The complex exhibits property for prolonged retention in blood stream after its administration that provides its applicability in treatment and prophylaxis of osseous metabolic diseases. The complex provides normalization of osseous metabolism. n EFFECT: valuable medicinal properties of complex, expanded assortment of agents. n 34 cl, 8 tbl, 8 ex |